Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03279523 · ClinicalTrials.gov registry record
F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected
A clinical trial, sponsored by Tammie L. S. Benzinger, MD, PhD.
- Completed
- Registry status
- 60
- Enrollment target
NCT03279523: Completed study, sponsored by Tammie L. S. Benzinger, MD, PhD.
NCT03279523 is a clinical trial that has completed, run by Tammie L. S. Benzinger, MD, PhD. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03279523 has completed, sponsored by Tammie L. S. Benzinger, MD, PhD.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This project will collect quantitative pilot data that will allow the characterization of uptake and binding of 18F-AV-1451 (also known as F 18 T807, also known as T807, also known as 7-(6-fluoropyridin-3-yl)-5H-pyrido\[4,3-b\]indole), a novel tau imaging compound, in older HIV+ individuals with and without HAND and matched HIV uninfected (HIV-) controls. The primary goal is to develop this highly promising tau imaging technique as an biomarker of cognitive decline in HIV+ individuals. The investigators will obtain preliminary data that will support the possibility of detecting early brain pathological changes due to HIV. Data generated from this study will be used for submission of National Institutes of Health (NIH) grants comparing tau deposition in HAND compared to other neurodegenerative disorders. It is hypothesized that specific topographies will help distinguish these neurodegenerative disorders in older individuals.
Interventions
- DRUG F 18 T807
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-05-03 |
| Est. Completion | 2018-05-23 |
What the finished NCT03279523 record still lists
NCT03279523 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which F 18 T807 is the first listed.
NCT03279523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03279523 about?
NCT03279523 is a clinical study titled "F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected". This project will collect quantitative pilot data that will allow the characterization of uptake and binding of 18F-AV-1451 (also known as F 18 T807, also known as T807, also known as 7-(6-fluoropyridin-3-yl)-5H-pyrido\[4,3-b\]indole), a novel tau imaging compound, in older HIV+ individuals with and...
What is the current status of trial NCT03279523?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2016-05-03. Estimated completion is 2018-05-23.
What interventions are being tested in trial NCT03279523?
The interventions under investigation include: F 18 T807 (DRUG).
Who is sponsoring clinical trial NCT03279523?
This trial is sponsored by Tammie L. S. Benzinger, MD, PhD, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI